BioSpace News Archive

Rakuten Medical, Inc. today announced that it will host a virtual R&D Day on Thursday, June 20, 2024 at 1:00 pm ET / 10:00 am PT.

Ceapro Inc. today announced financial results and operational highlights for the first quarter ended March 31, 2024.

Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe ® System, showing promise for improving the treatment of atrial fibrillation.

TransCode Therapeutics, Inc. today announced new preliminary data from its Phase 0 clinical trial with radiolabeled TTX-MC138 suggesting anti-tumor activity.

Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.

Paradigm announced results from a collaboration with Altru Health System (Altru) to improve the efficiency of its clinical research program and expand the availability of clinical research as a care option for patients spanning 46 locations across a rural catchment area of over 4,000 square miles in North Dakota and Minnesota.

Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director, business development.

Onera Health, a leader in transforming sleep medicine and remote monitoring, today announced its presence at the upcoming SLEEP 2024 conference, the 38th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 1-5, 2024, in Houston, United States.

Evergreen Nephrology is pleased to announce a new partnership with Western Kentucky Kidney Specialists.

Affimed N.V. announced that the FDA has granted Fast Track designation to the combination of its innate cell engager AFM24 with atezolizumab for the treatment of patients with advanced and/or metastatic non-small cell lung cancer not harboring any activating EGFR mutations after progression on PD-1 targeted therapy and platinum-based chemotherapy.